Search
News & Events
Researchers at The Kids push back against claims linking paracetamol to autismResearchers at The Kids Research Institute Australia have pushed back against claims by US President Donald Trump linking paracetamol use during pregnancy to autism.
CliniKids has two clinics - in Subiaco and also in Joondalup.
News & Events
Autism researcher named 40 under 40 finalistAndrew Whitehouse has been listed in the WA Business News 40 under 40 awards recognising accomplished and dynamic young leaders in Western Australia.
This series aims to provide some practical and evidence-based ideas to support your child and family.
Research
Fetal alcohol exposure, nutritional status and epigenetic disruption – exploring the linksAlexander David Martyn Larcombe Martino Symons BScEnv (Hons) PhD BSc PhD B.A. (Hons) PhD. Honorary Research Fellow Head, Chronic Diseases Research
Research
The epigenetic origin of alcohol-induced disorders: a cross-species studyAlexander David Martyn Larcombe Martino Symons BScEnv (Hons) PhD BSc PhD B.A. (Hons) PhD. Honorary Research Fellow Head, Chronic Diseases Research
Research
Prolonged Grief Disorder, but Not Death From COVID-19, Elicits Public Stigma: A Vignette-Based ExperimentWe investigated the effects of cause of death (COVID-19 with an underlying medical condition vs. without) and prolonged grief disorder status (PGD present or absent) on participants' reported public stigma towards the bereaved.
Research
The PROTECT TrialTobias Jenny Strunk Mountain Other Investigators MD, PhD, FRACP MBA MClinEpi Head, Neonatal Health Program Manager, Neonatal Health / Protect Trial
Research
Evaluation of Pediatric HIV Postexposure Prophylaxis Guideline Following Child Sexual Assault in Western AustraliaHIV postexposure prophylaxis (PEP) following child sexual assault (CSA) is recommended in select cases. High rates of poor adherence to PEP are reported. We evaluated adherence to the recommended management of children following CSA at the tertiary pediatric facility in Western Australia and compared our approach with international guidelines.
Research
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second boosterPICOBOO is a randomised, adaptive trial evaluating the immunogenicity, reactogenicity, and safety of COVID-19 booster strategies. We report data for second boosters among individuals 50-<70 years old primed with AZD1222 (50-<70y-AZD1222) until Day 84.